Recurrent hepatitis

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2017
02420002017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND & AIMS The aim of this study was to evaluate the results of treatment with pegylated interferon and ribavirin for the… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2014
2014
BACKGROUND We evaluated efficacy and safety of sofosbuvir and daclatasvir±ribavirin in liver transplant recipients with severe… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2014
2014
The value of transient elastography (TE) to assess clinical outcomes in hepatitis C recurrence after liver transplantation (LT… (More)
Is this relevant?
2009
2009
Antiviral therapy for recurrent hepatitis C in liver transplantation has been associated with the development of chronic… (More)
Is this relevant?
2007
2007
BACKGROUND/AIMS We performed a randomized trial on pegylated interferon alfa-2a (Peg-IFNalpha) monotherapy vs Peg-IFNalpha and… (More)
Is this relevant?
2007
2007
Adherence to antiviral therapy is essential to achieve sustained virological responses in patients treated for hepatitis C. An… (More)
Is this relevant?
2005
2005
Hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT) is almost universal. The optimal… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
1. After liver transplantation for hepatitis C virus (HCV)-related cirrhosis, recurrence of infection is universal, with… (More)
Is this relevant?
2002
2002
Although interferon alfa (IFN-alpha) and ribavirin are widely used in the treatment of hepatitis C, their role in the transplant… (More)
Is this relevant?
2001
2001
Hepatitis B virus (HBV) infection after liver transplantation (LT) may lead to severe and rapidly progressive graft failure… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?